CIK 0000715446
- Non-accelerated filer
- Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 112622630
- Phone
- +1 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Gift Director gave 300,000 shares (gift)
- 4 Exercise or conversion Director acquired 46,000 shares (option exercise)
- 4 Other acquisition President acquired 1,086 shares (other)
- 4 Open-market buy Director bought 10,000 shares at $2.79 ($27,900)
- 4 Open-market buy President bought 5,500 shares at $2.66 ($14,630)
- 4 Open-market buy President bought 2,509 shares at $2.53 ($6,348)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,000 shares at $3.28 ($16,400)
- 4 Open-market buy Director bought 2,000 shares at $3.20 ($6,400)
- 4 Open-market buy Director bought 6,000 shares at $3.08 ($18,480)
- 4 Open-market buy Director bought 11,000 shares at $3.08 ($33,880)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $3.00 ($60,000)
- 4 Other acquisition COO & CFO acquired 743 shares (other)
- 4 Open-market buy Director bought 18,244 shares at $4.76 ($86,841)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at $4.77 ($9,540)
Page 5 of 24 · 471 filings